1919 Investment Counsel’s Bausch Health BHC Stock Holding History

1919 Investment Counsel’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$86K	Buy	+650	New	+$77.5K	﹤0.01%	637

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BWA

Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

1919 Investment Counsel's BHC Position: Q3 2014 in Review

1919 Investment Counsel opened a new position in Bausch Health (BHC) in Q3 2014: 650 shares worth $86K. The stake represents ﹤0.01% of the portfolio and ranks #637 among its holdings.

454 funds tracked by Wall St. Rank hold BHC as of Q3 2014.

1919 Investment Counsel held 650 shares of Bausch Health worth $86K as of Q3 2014.
Bausch Health was a new 1919 Investment Counsel position in Q3 2014.
Bausch Health made up ﹤0.01% of 1919 Investment Counsel's portfolio in Q3 2014, its #637 holding.
454 funds tracked by Wall St. Rank held Bausch Health as of Q3 2014.

Based on 1919 Investment Counsel's 13F filing for Q3 2014, filed 14 Nov 2014.